Latest Period
Q1 2026
Security Snapshot
CAPRICOR THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (CAPR) Institutional Ownership
CUSIP: 14070B309
13F Institutional Holders and Ownership History from Q2 2019 to Q1 2026
Institutions Reporting
176
Shares (Excl. Options)
33,826,155
Price
$30.40
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- CAPR on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 33,826,155
- Total 13F value
- $1,027,338,953
- Portfolio coverage rank
- 0%
- Share change
- +5,646,491
- Value change
- +$175,240,758
- Number of holders
- 176
- Shares outstanding
- 51,786,227
- SEC-reported price per share
- $28.02
- Insider filing price
- $28.02
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- CAPR - CAPRICOR THERAPEUTICS, INC. - Common Stock, par value $0.001 per share is tracked under CUSIP 14070B309.
- 176 institutions reported positions in Q1 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 132 to 176 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $790,651,714 to $1,027,338,953.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 176 institutions filings for Q1 2026.
Security key
14070B309
Latest holder period
Q1 2026
13F holders
176
13D/G owners
5
CIK / CUSIP context first
Open Q1 2026 holders
CAPR full holder history
CAPRICOR THERAPEUTICS, INC. SEC filings
CAPRICOR THERAPEUTICS, INC. company facts
CAPRICOR THERAPEUTICS, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 14070B309:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
CAPR
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6.6% | $80,730,585 | 3,417,891 | SUVRETTA CAPITAL MANAGEMENT, LLC | 19 Feb 2026 | |||
| TANG CAPITAL MANAGEMENT LLC | 6.6% | $98,136,074 | 3,399,900 | TANG CAPITAL MANAGEMENT, LLC | 16 Jan 2026 | |||
| BlackRock, Inc. | 6.5% | $38,658,889 | 2,966,914 | BlackRock, Inc. | 31 Dec 2024 | |||
| VANGUARD GROUP INC | 4.8% | -4.4% | $15,910,444 | -$709,168 | 2,206,719 | -4.3% | The Vanguard Group | 30 Sep 2025 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2.3% | $29,748,000 | 1,200,000 | Highbridge Capital Management, LLC | 31 Dec 2025 |
As of 31 Mar 2026, 176 institutional investors reported holding 33,826,155 shares of CAPRICOR THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (CAPR). This represents 65% of the company’s total 51,786,227 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
52%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7.4% | 3,818,600 | +114% | 3.1% | $116,085,440 |
| BlackRock, Inc. | 6.6% | 3,421,815 | +20% | 0% | $104,023,174 |
| TANG CAPITAL MANAGEMENT LLC | 6.6% | 3,399,900 | +100% | 5.2% | $103,356,960 |
| STATE STREET CORP | 4.2% | 2,181,901 | +163% | 0% | $66,329,790 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.9% | 2,027,732 | 0% | 0% | $61,643,053 |
| RA CAPITAL MANAGEMENT, L.P. | 2.9% | 1,507,844 | 0% | 0.49% | $45,838,458 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.2% | 1,118,326 | +9.9% | 0% | $34,002,865 |
| GOLDMAN SACHS GROUP INC | 1.8% | 911,976 | +104% | 0% | $27,724,070 |
| Jones Hill Capital LP | 1.8% | 909,207 | 0% | 5.9% | $27,639,893 |
| Point72 Asset Management, L.P. | 1.6% | 821,179 | -55% | 0.04% | $24,963,842 |
| FMR LLC | 1.5% | 772,649 | -16% | 0% | $23,488,518 |
| Boxer Capital Management, LLC | 1.1% | 590,000 | +82% | 2.4% | $17,936,000 |
| JANE STREET GROUP, LLC | 1.1% | 566,081 | 0.02% | $17,208,863 | |
| J. Goldman & Co LP | 1% | 541,522 | -9% | 0.76% | $16,462,269 |
| CITADEL ADVISORS LLC | 1% | 539,232 | -40% | 0.01% | $16,392,652 |
| Ikarian Capital, LLC | 1% | 528,015 | -8.7% | 2.3% | $16,051,656 |
| MORGAN STANLEY | 0.82% | 423,819 | -28% | 0% | $12,884,097 |
| NORTHERN TRUST CORP | 0.81% | 417,543 | +19% | 0% | $12,693,308 |
| BANK OF AMERICA CORP /DE/ | 0.8% | 415,483 | +672% | 0% | $12,630,683 |
| MERCER GLOBAL ADVISORS INC /ADV | 0.78% | 402,999 | 0.02% | $12,251,170 | |
| DG Capital Management, LLC | 0.76% | 392,096 | -5.3% | 5.2% | $11,919,718 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.73% | 379,214 | 0% | 0% | $11,528,106 |
| UBS Group AG | 0.72% | 371,984 | +56% | 0% | $11,308,313 |
| MILLENNIUM MANAGEMENT LLC | 0.69% | 356,354 | -48% | 0.01% | $10,833,162 |
| JPMORGAN CHASE & CO | 0.66% | 343,613 | -6.9% | 0% | $9,542,134 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
28
Latest
Q1 2026
Rows shown
1-25 of 28
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 33,826,155 | $1,027,338,953 | +$175,240,758 | $30.40 | 176 |
| 2025 Q4 | 27,422,288 | $790,651,714 | +$390,644,574 | $28.86 | 132 |
| 2025 Q3 | 14,454,970 | $104,098,244 | +$3,052,047 | $7.21 | 115 |
| 2025 Q2 | 13,740,752 | $136,510,446 | -$45,087,125 | $9.93 | 105 |
| 2025 Q1 | 18,332,527 | $174,018,005 | +$4,472,871 | $9.49 | 120 |
| 2024 Q4 | 17,327,955 | $239,127,553 | +$123,239,591 | $13.80 | 107 |
| 2024 Q3 | 8,369,327 | $127,297,422 | +$33,779,392 | $15.21 | 75 |
| 2024 Q2 | 6,426,234 | $30,652,576 | +$6,579,081 | $4.77 | 60 |
| 2024 Q1 | 4,817,759 | $32,711,658 | +$5,474,658 | $6.79 | 55 |
| 2023 Q4 | 4,019,035 | $19,652,993 | -$3,283,556 | $4.89 | 37 |
| 2023 Q3 | 5,536,583 | $18,934,429 | +$9,929,580 | $3.42 | 34 |
| 2023 Q2 | 2,624,364 | $12,543,954 | +$927,959 | $4.78 | 32 |
| 2023 Q1 | 2,433,746 | $10,269,762 | -$1,225,035 | $4.22 | 30 |
| 2022 Q4 | 2,739,017 | $10,569,409 | -$271,547 | $3.86 | 31 |
| 2022 Q3 | 2,792,373 | $16,752,192 | +$1,609,613 | $6.00 | 28 |
| 2022 Q2 | 2,543,515 | $8,872,518 | -$139,327 | $3.49 | 27 |
| 2022 Q1 | 2,589,186 | $8,879,200 | +$964,475 | $3.43 | 26 |
| 2021 Q4 | 2,320,262 | $6,798,547 | -$740,098 | $2.93 | 24 |
| 2021 Q3 | 2,490,642 | $10,025,330 | -$5,545,456 | $4.02 | 25 |
| 2021 Q2 | 3,528,427 | $18,097,220 | -$4,296,483 | $5.13 | 26 |
| 2021 Q1 | 4,384,650 | $20,517,844 | +$13,558,859 | $4.68 | 28 |
| 2020 Q4 | 1,499,334 | $5,140,899 | +$692,978 | $3.43 | 24 |
| 2020 Q3 | 1,264,478 | $6,640,688 | +$1,920,376 | $5.25 | 25 |
| 2020 Q2 | 940,377 | $4,324,870 | +$2,983,542 | $4.60 | 30 |
| 2020 Q1 | 498,312 | $597,000 | +$332,841 | $1.20 | 15 |